behÇet’s disease patient summit...in this moderated discussion, two patients living with...
TRANSCRIPT
BEHÇET’S DISEASE PATIENT SUMMIT
Free of charge
Saturday, November 9, 2019 • 9:00 am - 12:30 pm • Renaissance Atlanta Midtown • Atlanta, GA
SATURDAY, NOVEMBER 9Registration will begin at 7:45 am. Please check in, pick up your name badge and enjoy the opportunity to network with members of the Behçet’s Disease community over breakfast.
TIME SESSION SPEAKERS
7:45 – 9:00 am
9:00 – 9:10 am
Registration & Networking Breakfast
12:15 – 12:30 pm Thank You
12:30 – 1:30 pm Networking Lunch
Summit Welcome Catherine FerroneDirector, Patient Advocacy, Inflammation & Immunology at Celgene
9:10 – 9:30 am Understanding Behçet’s Disease Learn about the symptoms, causes and what leads to a diagnosis of Behçet’s Disease.
Dr. Andrew Sulich Shores Rheumatology, PC, Saint Clair Shores, MI
9:30 – 9:40 am A Treatment Option for Patients
9:40 – 9:50 am Break
Dr. Andrew Sulich Shores Rheumatology, PC, Saint Clair Shores, MI
Dr. Andrew Sulich Shores Rheumatology, PC, Saint Clair Shores, MI
10:35 – 10:45 am Break
9:50 – 10:35 am Physician Perspective: Coordinating Behçet's Disease Care A panel of multidisciplinary healthcare professionals will lead a moderated discussion on the following topics:
— How Behçet’s Disease affects the body — How different specialties can work together to find
manageable solutions — Lifestyle changes you can make to help manage manifestations
Moderated by Joyce Kullman Executive Director, Vasculitis Foundation
Dr. Glenn ParrisParris & Associates, Lawrenceville, GA
10:45 – 11:30 am Patient Perspective: Living with Behçet’s Disease In this moderated discussion, two patients living with Behcet's Disease and a caregiver will share their personal experiences on:
— How to manage challenging symptoms — Coping with the disease in daily life— Tips to improve your next doctor’s appointment
(e.g., documenting flare ups) — Hope for living better with a chronic condition
Moderated by Deb Kleber StruzynaPresident, American Behçet’s Disease Association Board
Dr. Robert MichelettiAssistant Professor of Dermatology, Hospital of the University of Pennsylvania
AlisaAtlanta, GA
AshleyPhiladelphia, PA
NickPhiladelphia, PA
11:30 am – 12:15 pm The Power of Your Story Discover the potential benefits of journaling for both personal reflection and as a tool for sharing your experience with others in this session led by The Mighty, a leading online community that supports and empowers people with health challenges and disabilities.
Sarah SchusterEditorial Director, Contributors, The Mighty
Catherine FerroneDirector, Patient Advocacy, Inflammation & Immunology at Celgene
10/19 US-CLG-19-1517
Sponsored by Co-Hosted by Content is intended for U.S. audiences.
10/19 US-CLG-19-1517
@behcets_usa
American Behcet’s Disease Association – ABDA (@ABDA_Behcets)
@VasculitisFound
Vasculitis Foundation (@VasculitisFoundation)
@vasculitisfoundation
@behcets_usa
PHOTO AND VIDEO RELEASEThe American Behçet’s Disease Association and the Vasculitis Foundation, as well as our sponsor Celgene, use electronic and traditional media including, but not limited to photographs, video, audio and testimonials recorded during the summit. All attendees, speakers and guests are advised that during the summit, photographs will be taken as well as audio and video recordings made of various activities and sessions. The educational sessions and panel discussions at today’s patient summit will be live streamed and recorded for future viewing by members of the Behçet’s Disease community who were unable to attend in person.
Each attendee grants these organizations permission to use the images in any media for any noncommercial and/or commercial purpose, and waive any right to inspect or approve any final product utilizing the images.
SOCIAL MEDIAPlease share your experiences using the hashtag #BehcetsDisease so others can follow the conversation – and be sure to visit our photo station.
American Behçet’s Disease Association
Vasculitis Foundation
Sponsored by Co-Hosted by
Content is intended for U.S. audiences.